PT2448968T - ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL - Google Patents
ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINALInfo
- Publication number
- PT2448968T PT2448968T PT107397010T PT10739701T PT2448968T PT 2448968 T PT2448968 T PT 2448968T PT 107397010 T PT107397010 T PT 107397010T PT 10739701 T PT10739701 T PT 10739701T PT 2448968 T PT2448968 T PT 2448968T
- Authority
- PT
- Portugal
- Prior art keywords
- alzheimer
- oligomers
- therapeutic
- disease
- diagnostic methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22110509P | 2009-06-29 | 2009-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2448968T true PT2448968T (pt) | 2021-04-30 |
Family
ID=42832352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT107397010T PT2448968T (pt) | 2009-06-29 | 2010-06-29 | ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20120100129A1 (pt) |
| EP (2) | EP3892633A1 (pt) |
| JP (3) | JP2012532094A (pt) |
| AU (1) | AU2010267640B2 (pt) |
| CA (1) | CA2765602C (pt) |
| CY (1) | CY1124034T1 (pt) |
| DK (1) | DK2448968T3 (pt) |
| ES (1) | ES2864049T3 (pt) |
| HR (1) | HRP20210611T1 (pt) |
| HU (1) | HUE053949T2 (pt) |
| LT (1) | LT2448968T (pt) |
| PL (1) | PL2448968T3 (pt) |
| PT (1) | PT2448968T (pt) |
| SI (1) | SI2448968T1 (pt) |
| SM (1) | SMT202100237T1 (pt) |
| WO (1) | WO2011001366A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401601D0 (sv) | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| ATE492561T1 (de) | 2006-03-23 | 2011-01-15 | Bioartic Neuroscience Ab | Verbesserte protofibrilselektive antikörper und deren verwendung |
| HUE038313T2 (hu) | 2010-02-26 | 2018-10-29 | Bioarctic Neuroscience Ab | Protofibril-kötõ antitestek és alkalmazásuk Parkinson-kór, Lewy-testes demencia és más alfa-szinukleinopátiák terápiás és diagnosztikai eljárásaiban |
| SG192805A1 (en) | 2011-03-16 | 2013-09-30 | Probiodrug Ag | Diagnostic antibody assay |
| HRP20210680T1 (hr) | 2014-07-10 | 2021-06-11 | Bioarctic Ab | POBOLJŠANA PROTUTIJELA KOJA VEŽU Aβ PROTOFIBRIL |
| CN107849125A (zh) | 2015-07-21 | 2018-03-27 | 生命北极神经科学公司 | 用于治疗靶向聚集的肽的创伤性脑损伤的方法 |
| MA45684A (fr) | 2016-07-14 | 2019-05-22 | Bioarctic Neuroscience Ab | Protéine d'apport du cerveau |
| WO2019023247A1 (en) | 2017-07-25 | 2019-01-31 | Immutics, Inc. | TREATMENT OF CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND |
| CA3107370A1 (en) | 2018-07-24 | 2020-01-30 | Eisai R&D Management Co., Ltd. | Methods of treatment and prevention of alzheimer's disease |
| JP2022523333A (ja) | 2019-01-30 | 2022-04-22 | トゥルーバインディング，インコーポレイテッド | 抗ｇａｌ３抗体およびその使用 |
| US20220251518A1 (en) * | 2019-07-08 | 2022-08-11 | Terumo Kabushik Kaisha | Hybridoma, method for making the same, monoclonal antibody, and method for making the same |
| WO2021055670A1 (en) | 2019-09-20 | 2021-03-25 | Avx Corporation | Somatic cell-based electrical biosensor |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| MX2022016005A (es) | 2020-06-26 | 2023-02-02 | Bioarctic Ab | Anticuerpos de fijacion a protofibrillas de \03b1-sinucleina. |
| US20250163135A1 (en) | 2021-07-09 | 2025-05-22 | Eisai R&D Management Co., Ltd. | Biomarkers for alzheimer's disease treatment |
| KR20240053620A (ko) | 2021-08-30 | 2024-04-24 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 항-a베타 프로토피브릴 항체의 피하 제형 및 이를 사용하는 방법 |
| KR20240142535A (ko) | 2022-02-02 | 2024-09-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | P-tau181 수준을 사용한 치료 방법 |
| TW202440628A (zh) | 2022-12-22 | 2024-10-16 | 瑞典商生物極公司 | 新抗體 |
| WO2025262228A1 (en) | 2024-06-20 | 2025-12-26 | Bioarctic Ab | Bispecific binding molecule |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5604102A (en) | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| AU6524500A (en) * | 1999-08-04 | 2001-03-05 | Northwestern University | Amyloid beta protein (globular assembly and uses thereof) |
| EP2082749A3 (en) | 2000-07-07 | 2010-06-30 | Bioarctic Neuroscience AB | Prevention and treatment of Alzheimer's disease |
| US7122374B1 (en) * | 2002-04-09 | 2006-10-17 | Takaomi Saido | Amyloid beta-protein 3(pE)-42 antibodies and uses thereof |
| AU2003250102B2 (en) * | 2002-07-24 | 2009-09-17 | Innogenetics N.V. | Fragments of beta-amyloid as targets for vaccination against alzheimer disease |
| EP2374817B1 (en) * | 2004-04-13 | 2017-09-06 | F. Hoffmann-La Roche AG | Anti-P-selectin antibodies |
| GB0413726D0 (en) * | 2004-06-18 | 2004-07-21 | Lauras As | Compounds |
| SE0401601D0 (sv) * | 2004-06-21 | 2004-06-21 | Bioarctic Neuroscience Ab | Protofibril specific antibodies and uses thereof |
| MX2007000998A (es) * | 2004-07-30 | 2007-07-11 | Rinat Neuroscience Corp | Anticuerpos dirigidos peptido beta-amiloide y procedimientos que usan los mismos. |
| ATE492561T1 (de) * | 2006-03-23 | 2011-01-15 | Bioartic Neuroscience Ab | Verbesserte protofibrilselektive antikörper und deren verwendung |
| KR101377535B1 (ko) * | 2007-11-16 | 2014-03-27 | 더 락커펠러 유니버시티 | 원섬유 형태의 베타아밀로이드 단백질에 대해 특이적인 항체 |
| PT2282758T (pt) * | 2008-04-29 | 2019-02-12 | Bioarctic Ab | Anticorpos e vacinas para uso em métodos terapêuticos e diagnósticos para perturbações relacionadas com a alfa-sinucleína |
-
2010
- 2010-06-29 LT LTEP10739701.0T patent/LT2448968T/lt unknown
- 2010-06-29 EP EP21153326.0A patent/EP3892633A1/en active Pending
- 2010-06-29 JP JP2012516964A patent/JP2012532094A/ja not_active Withdrawn
- 2010-06-29 PT PT107397010T patent/PT2448968T/pt unknown
- 2010-06-29 US US13/379,523 patent/US20120100129A1/en not_active Abandoned
- 2010-06-29 ES ES10739701T patent/ES2864049T3/es active Active
- 2010-06-29 HU HUE10739701A patent/HUE053949T2/hu unknown
- 2010-06-29 CA CA2765602A patent/CA2765602C/en active Active
- 2010-06-29 HR HRP20210611TT patent/HRP20210611T1/hr unknown
- 2010-06-29 SM SM20210237T patent/SMT202100237T1/it unknown
- 2010-06-29 WO PCT/IB2010/052947 patent/WO2011001366A1/en not_active Ceased
- 2010-06-29 SI SI201032068T patent/SI2448968T1/sl unknown
- 2010-06-29 DK DK10739701.0T patent/DK2448968T3/da active
- 2010-06-29 EP EP10739701.0A patent/EP2448968B1/en active Active
- 2010-06-29 AU AU2010267640A patent/AU2010267640B2/en active Active
- 2010-06-29 PL PL10739701T patent/PL2448968T3/pl unknown
-
2017
- 2017-04-19 JP JP2017083057A patent/JP6884025B2/ja active Active
-
2019
- 2019-08-01 JP JP2019142344A patent/JP2019218362A/ja active Pending
-
2021
- 2021-04-27 CY CY20211100361T patent/CY1124034T1/el unknown
-
2022
- 2022-12-15 US US18/066,998 patent/US20230295283A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017197531A (ja) | 2017-11-02 |
| AU2010267640A1 (en) | 2012-01-19 |
| ES2864049T3 (es) | 2021-10-13 |
| AU2010267640B2 (en) | 2015-03-05 |
| CY1124034T1 (el) | 2022-05-27 |
| EP3892633A1 (en) | 2021-10-13 |
| DK2448968T3 (da) | 2021-04-12 |
| CA2765602C (en) | 2021-05-25 |
| JP6884025B2 (ja) | 2021-06-09 |
| LT2448968T (lt) | 2021-05-10 |
| WO2011001366A1 (en) | 2011-01-06 |
| EP2448968A1 (en) | 2012-05-09 |
| US20120100129A1 (en) | 2012-04-26 |
| US20230295283A1 (en) | 2023-09-21 |
| SI2448968T1 (sl) | 2021-07-30 |
| HUE053949T2 (hu) | 2021-08-30 |
| JP2019218362A (ja) | 2019-12-26 |
| JP2012532094A (ja) | 2012-12-13 |
| HRP20210611T1 (hr) | 2021-05-28 |
| PL2448968T3 (pl) | 2021-09-13 |
| SMT202100237T1 (it) | 2021-05-07 |
| EP2448968B1 (en) | 2021-01-27 |
| CA2765602A1 (en) | 2011-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2448968T (pt) | ANTICORPOS SELETIVOS PARA PROTOFIBRILAS/OLIGÓMEROS DE ß- AMILOIDE TRUNCADA EM N-TERMINAL | |
| LT2282758T (lt) | Antikūnai ir vakcinos, skirti su alfa sinukleinu susijusių sutrikimų gydymo ir diagnostiniams metodams | |
| IL215842A0 (en) | Intrauterine system for use in medical treatment | |
| PL2393399T3 (pl) | Materac przeznaczony do użytku w domach opieki i szpitalach | |
| LT2539366T (lt) | Protofibriles surišantys antikūnai ir jų panaudojimas parkinsono ligos, demencijos su levi kūneliais ir kitų alfa-sinukleinopatijų terapiniuose ir diagnostiniuose būduose | |
| LT2758433T (lt) | Alzheimerio ligos tau-sąlygojamos patologijos terapija ir diagnostika baltymų pagrindu | |
| ZA201107085B (en) | Indolizine derivative and use thereof for medical purposes | |
| IL220684A (en) | Anaphylactic therapy for Alzheimer's and the aging brain | |
| IL216702A0 (en) | Pharmaceutical composition for use in medical and veterinary ophthal mology | |
| EP2182978A4 (en) | TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN | |
| PT2405928T (pt) | Métodos de tratamento e de diagnóstico para patologias de hipersensibilidade | |
| PL2410922T3 (pl) | Urządzenie do przeprowadzania procedur diagnostycznych i/lub terapeutycznych | |
| GB201121597D0 (en) | Polyurethane oligomers for use in restorative dentistry | |
| GB0918392D0 (en) | Diagnostic and therapeutic methods | |
| ZA201106056B (en) | Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention | |
| GB0908868D0 (en) | Depsipeptide and their therapeutic use | |
| PT2470066E (pt) | Método não invasivo para avaliação da perfusão de tecidos num doente | |
| PL2565184T3 (pl) | Środek terapeutyczny i środek zapobiegawczy przeciwko chorobie alzheimera | |
| GB0905970D0 (en) | Depsipeptides and their therapeutic use | |
| IL216717A0 (en) | USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES | |
| IL218400A0 (en) | Compact probe for tracer-assisted diagnostic and surgery | |
| PL2459721T3 (pl) | Udoskonalony system ekspresji ludzkiej długiej pentraksyny i jego zastosowania | |
| IL219256A0 (en) | System and method for noninvasive tissue examination | |
| GB0910048D0 (en) | Methods and preparations for curing multiple organ dysfunction in clinically ill patients | |
| GB201008106D0 (en) | Cell protective peptides for treating diseases and disorders associated with tissue damage |